IoT Medical Devices Market by Product (Blood Pressure Monitor, Glucometer, Cardiac Monitor, Pulse Oximeter, Infusion Pump), Type (Wearable, Implantable, Stationary), Connectivity Technology (Bluetooth, Wifi), End User (Hospital) - Global Forecast to 2026", The global IoT medical devices market is projected to reach USD 94.2 billion by 2026 from USD 26.5 billion in 2021, at a CAGR of 28.9% during the forecast period. The growth of this market is majorly attributed to the need for cost-containment in healthcare delivery, and rising focus on active patient engagement patient-centric care delivery. Also, the government initiatives to promote digital health are expected to drive demand growth in the IoT medical devices market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15629287
Browse in-depth TOC on "IoT Medical Devices Market”
231– Tables
50– Figures
309– Pages
Key Market
The major players in the global IoT medical devices market are Medtronic (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands). Other prominent players in the market include Honeywell Life Care Solutions (US), BIOTRONIK (Germany) are the leading players in the market. Other players include Boston Scientific Corporation (US), Johnson Johnson Services, Inc. (US), Siemens AG (Germany), Omron Healthcare, Inc. (Japan), BioTelemetry, Inc. (US), AliveCor, Inc. (US), iHealth Lab, Inc. (US), AgaMatrix (US), Abbott Laboratories (US), Stanley Healthcare (US), and Hillrom-Welch Allyn (US).
Medtronic (US) held the leading position in the IoT medical devices market in 2020. The company has a strong product portfolio of wearable, implantable, and stationary medical devices that are IoT-enabled. Medtronic focuses on designing and manufacturing devices to address cardiac care, neurological spinal conditions, and diabetes. The company is focusing on inorganic growth strategies such as acquisitions, partnerships, and collaborations for its growth. It has partnered with top brands in the IoT space, such as IBM, Fitbit, Qualcomm Life, and Samsung, to offer its customers the most advanced healthcare technology.
GE Healthcare (US) held the second position in the IoT medical devices market in 2020. The company has a comprehensive portfolio of wearable and stationary IoT-enabled medical devices. GE Healthcare focuses on developing innovative products that cater to the evolving trends in the market and help clinicians provide advanced care to patients. The company has a significant focus on upgrading its existing products. The company also focuses on inorganic growth strategies like collaborations, partnerships, agreements, and acquisitions. The company collaborated with governments of emerging nations to digitalize the healthcare sector. GE Healthcare’s strong presence in 140 countries also helps it market its products across the globe.
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=15629287
North America dominates the IoT medical devices market during the forecast period.
North America accounted for the largest share of the IoT medical devices market in 2020. The high penetration of smartphones, tablets, and other mobile platforms; increasing utilization of connected devices to manage chronic diseases; the development and adoption of EHRs in healthcare organizations; and rising government initiatives for digitizing healthcare are some of the factors driving the growth of the IoT medical devices market in this region.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=15629287
Browse Adjacent Market: 3D Bioprinting Market Research Reports Consulting
Related Reports:
NGS-Based RNA-Sequencing Market by Product Services (Sample Preparation, Platforms Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/breast-augmentation-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/breast-augmentation.asp
Our Other Reports:
